Works matching IS 14642662 AND DT 2023 AND VI 24 AND IP 8

Results: 10

Tenofovir alafenamide and weight: What do we still need to know to inform clinical decisions?

Published in:

HIV Medicine, 2023, v. 24, n. 8, p. 857, doi. 10.1111/hiv.13497

By:

Surial, Bernard;
Wandeler, Gilles

Publication type:

Article

How are HIV services in the UK currently identifying and managing patients with cognitive impairment? Results of a national survey.

Published in:

HIV Medicine, 2023, v. 24, n. 8, p. 946, doi. 10.1111/hiv.13494

By:

Morris, Rebekah;
Alford, Kate;
Vera, Jaime H.

Publication type:

Article

Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real‐world setting in Belgium.

Published in:

HIV Medicine, 2023, v. 24, n. 8, p. 914, doi. 10.1111/hiv.13493

By:

Nasreddine, Rakan;
Florence, Eric;
Yombi, Jean Cyr;
Henrard, Sophie;
Darcis, Gilles;
Van Praet, Jens;
Vandekerckhove, Linos;
Allard, Sabine D.;
Demeester, Rémy;
Messiaen, Peter;
Ausselet, Nathalie;
Delforge, Marc;
De Wit, Stéphane

Publication type:

Article

Barriers and facilitators to HIV Pre‐Exposure Prophylaxis (PrEP) in Specialist Sexual Health Services in the United Kingdom: A systematic review using the PrEP Care Continuum.

Published in:

HIV Medicine, 2023, v. 24, n. 8, p. 893, doi. 10.1111/hiv.13492

By:

Coukan, Flavien;
Murray, Keitumetse‐Kabelo;
Papageorgiou, Vasiliki;
Lound, Adam;
Saunders, John;
Atchison, Christina;
Ward, Helen

Publication type:

Article

Perception of PrEP‐related stigma in PrEP users: Results from the ANRS‐PREVENIR cohort.

Published in:

HIV Medicine, 2023, v. 24, n. 8, p. 938, doi. 10.1111/hiv.13491

By:

Protiere, C.;
Sagaon‐Teyssier, L.;
Donadille, C.;
Sow, A.;
Gaubert, G.;
Girard, G.;
Mora, M.;
Assoumou, L.;
Beniguel, L.;
Michels, D.;
Ghosn, J.;
Costagliola, D.;
Rojas Castro, D.;
Molina, J.‐M.;
Spire, B.

Publication type:

Article

The recent natural history of human papillomavirus cervical infection in women living with HIV: A scoping review of meta‐analyses and systematic reviews and the construction of a hypothetical model.

Published in:

HIV Medicine, 2023, v. 24, n. 8, p. 877, doi. 10.1111/hiv.13490

By:

Gilles, Christine;
Konopnicki, Déborah;
Rozenberg, Serge

Publication type:

Article

Efficacy and safety of dolutegravir/rilpivirine in real‐world clinical practice. GeSIDA study 1119.

Published in:

HIV Medicine, 2023, v. 24, n. 8, p. 933, doi. 10.1111/hiv.13489

By:

Palacios, R.;
Gómez‐Ayerbe, C.;
Casado, J. L.;
Tejerina, F.;
Montes, M. L.;
Castaño, M.;
Ocampo, A.;
Rial, D.;
Ribera, E.;
Galindo, M. J.;
Hidalgo, C.;
Fariñas, C.;
Montero, M.;
Payeras, T.;
Fanjul, F.;
de la Torre, J.;
Santos, J.

Publication type:

Article

Weight gain following the single substitution of tenofovir disoproxil fumarate by tenofovir alafenamide in HIV‐infected people from the French Dat'AIDS cohort: A propensity score‐matched analysis.

Published in:

HIV Medicine, 2023, v. 24, n. 8, p. 925, doi. 10.1111/hiv.13488

By:

Hocqueloux, Laurent;
Menard, Amélie;
Arvieux, Cédric;
Joly, Véronique;
Becker, Agathe;
Chéret, Antoine;
Duvivier, Claudine;
Cabié, André;
Delpierre, Cyrille;
Allavena, Clotilde

Publication type:

Article

Advanced HIV disease: A review of diagnostic and prophylactic strategies.

Published in:

HIV Medicine, 2023, v. 24, n. 8, p. 859, doi. 10.1111/hiv.13487

By:

Lehman, Alice;
Ellis, Jayne;
Nalintya, Elizabeth;
Bahr, Nathan C.;
Loyse, Angela;
Rajasingham, Radha

Publication type:

Article

Issue Information.

Published in:: HIV Medicine, 2023, v. 24, n. 8, p. 855, doi. 10.1111/hiv.13341
Publication type:: Article